Insurance AI Consulting vs Insurtech Platforms: When to Build vs Buy
Platforms fit commodity workflows; consulting builds fit owned appetite, PAS-deep integration, and agentic orchestration. A practical build-vs-buy guide for carriers and MGAs choosing insurance AI partners.
Insurance buyers evaluating AI in 2026 face a false binary sold by two camps: insurtech platforms that promise configure-not-code, and consultancies that promise bespoke advantage. Both can be right. Both are expensive when chosen for the wrong job. The useful question is which layers of your value chain should be purchased as product and which must be built as owned capability.
This is a selection guide for leaders comparing insurance AI consulting against platform buyouts, with particular relevance to MGA specialty P&C workflows and agentic development programs.
What insurtech platforms are optimized for
Platforms win when the workflow is common, the integration surface is already supported, and speed-to-pilot matters more than deep differentiation. Typical fits:
- Commodity document extraction with standard ACORD-heavy intake
- FNOL chat or policyholder Q&A with constrained knowledge bases
- Point solutions (content, underwriting workbench widgets) with clean APIs
- Programs where vendor roadmap aligns with your line mix for 2+ years
Platforms struggle when your appetite logic, distribution model, or claims handling is the product. Configuring around a vendor's object model can cost more than building the thin layer you actually needed.
What consulting builds are optimized for
Custom builds (or heavily owned implementations) win when:
- Workflow IP is a competitive moat you do not want shared with a vendor roadmap
- PAS / core constraints require deep integration the platform doesn't ship
- Regulatory or reinsurer scrutiny demands explainability you control end-to-end
- You need agentic orchestration across internal tools the vendor can't reach
Consulting is the wrong buy when you primarily need a maintained SaaS feature and lack appetite to own engineering. Paying senior builders to recreate a commodity portal is how AI budgets become cautionary tales.
Build vs buy by insurance layer
- Distribution / portal UX: Prefer buy or extend existing portals unless UX is your market wedge.
- Submission intake & appetite scoring: Hybrid—buy extraction, build appetite-as-code and routing for specialty MGAs.
- Underwriting decisioning: Own the decision policy; buy commodity data enrichments.
- Claims triage: Buy for personal lines volume; build when commercial complexity and SIU workflows dominate.
- Agentic assistants across systems: Usually build (or agentic development partnership)—platforms rarely span your full tool graph safely.
Cost models buyers misread
Platform pricing looks cheaper until you add implementation partners, per-seat creep, overage on documents, and the internal team mapping your exceptions into their schema. Consulting pricing looks expensive until you amortize owned IP across lines and avoid 5–7 years of road-map rent.
- Model 3-year TCO with exit costs, not year-one license
- Include exception labor—software never deletes the queue entirely
- Price integration as a first-class line item, not a hopeful assumption
- Demand reference architectures that match your PAS, not a greenfield demo
Decision checklist
- Is this workflow differentiating? If yes, bias to own. If no, bias to buy.
- Can a platform hit 80% without contortions?If reaching the last 20% requires fighting the product, you'll pay twice.
- Who carries model and prompt change risk? Exams and reinsurers care. Ambiguity here is a future finding.
- What is the exit? Data export, rule export, and replacement path should be contractual.
- Do you have owners? Bought software without product ownership becomes shelfware; built software without owners becomes abandonware.
A pragmatic default for MGAs and specialty carriers
For most specialty MGA shops in 2026: buy commodity extraction and data services; build intake scoring, appetite enforcement, and cross-system orchestration; keep underwriting authority firmly in your governance model. Use consulting to accelerate the owned layers—not to rubber-stamp a platform that already fits.
If you want a blunt build-vs-buy read on a specific workflow, bring your PAS, submission mix, and vendor shortlist. Our insurance AIteam will tell you which parts to purchase and which to own—and we won't pretend a platform is a strategy.
Deciding build vs buy for insurance AI?
We help carriers and MGAs choose consulting builds vs insurtech platforms with clear economics and integration reality. Bring your workflow and PAS constraints to a discovery call.